Sign Up Today and Learn More About SOMAĆ Pharmaceuticals Stock
Invest in or calculate the value of your shares in SOMAĆ Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
SOMAĆ Pharmaceuticals Stock (SOPH)
SOMAĆ Pharmaceuticals is a pharmaceutical and biotech company that specializes in cannabinoid-containing pharmaceutical medicines.
About SOMAĆ Pharmaceuticals Stock
Founded
2019
Industries
Software, Artificial Intelligence, Data and Analytics
SOMAĆ Pharmaceuticals Press Mentions
Stay in the know about the latest news on SOMAĆ Pharmaceuticals
Airo Medical Inhalation Device Launches in Germany with SOMAĆ EU-GMP Inhalation Extracts
einpresswire ā¢ Mar 24, 2026
Airo Medical InhalationsgerƤt ab sofort in Apotheken der wichtigsten medizinischen MƤrkte erhƤltlich
einpresswire ā¢ Mar 24, 2026
SOMAĆ Partners with Japanās KISEKI to Introduce Japanese-Quality Medicinal Cannabis to Global Medical Markets
einpresswire ā¢ Feb 17, 2026
Please wait while your request is being verified...
cannareporter ā¢ Feb 09, 2026
The Problem of Consistency in Local and Global Cannabis Branding
krautinvest ā¢ Feb 09, 2026
SOMAĆ Pharmaceuticals Management
Leadership team at SOMAĆ Pharmaceuticals
Chief Operating Officer and Co-Founder
George Bellow
Founder, Chairman and CEO
Michael Sassano
Join now and verify your accreditation status to gain access to:
- SOMAĆ Pharmaceuticals Current Valuation
- SOMAĆ Pharmaceuticals Stock Price
- SOMAĆ Pharmaceuticals Management
- Available deals in SOMAĆ Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- SOMAĆ Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- SOMAĆ Pharmaceuticals Revenue and Financials
- SOMAĆ Pharmaceuticals Highlights
- SOMAĆ Pharmaceuticals Business Model
- SOMAĆ Pharmaceuticals Risk Factors
- SOMAĆ Pharmaceuticals Research Report from SACRA Research
Trading SOMAĆ Pharmaceuticals Stock
How to invest in SOMAĆ Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like SOMAĆ Pharmaceuticals through EquityZen funds. These investments are made available by existing SOMAĆ Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event ā house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell SOMAĆ Pharmaceuticals stock?
Shareholders can sell their SOMAĆ Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
